Research article · 10 Dec 2025
ArticlePublished 2019
Rituximab as a treatment for limbic encephalitis associated with leucine-rich glioma inactivated-1: A case report and literature review.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Leucine-rich glioma-inactivated-1 (LGI1) protein antibody-associated limbic encephalitis (LE) is a treatable autoimmune disease. This report is about the administration of rituximab in two patients with LGI1 antibody-associated LE. Both patients had progressive confusion, behavioral alteration, memory impairment and temporal lobe seizures. Treatment included steroids, intravenous immunoglobulin (IVIG) and rituximab. Patients showed a positive response to the therapy. Both patients satisfactorily tolerated rituximab and neither experienced side effects. We also reviewed the recommended treatments for the LGI1 LE. Based on the recent reports, rituximab has the potential to become one of the treatment options for LE. Nevertheless, more evidence is necessary in order to accurately evaluate its efficacy.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Biomedical Research.
Research article · 7 Oct 2025
Multimarker Approach to Assess Glycemic Control and Bone Metabolism in Type 2 Diabetes Mellitus with Potential for Enhanced Clinical Monitoring
Review article · 13 Aug 2025
Inventions in Telemedicine Shaping the Post-Pandemic Landscape: A Complete Review of Its Revolution and Influence in the USA
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomedical Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Behnam Safarpour Lima”
- BylineArticles whose byline prints “Mahtab Ramezani”
- BylineArticles whose byline prints “Ehsan Karimialavijeh”
- BylineArticles whose byline prints “Sepideh Paybast”
- BylineArticles whose byline prints “Nahid Beladimoghadam”
- BylineArticles whose byline prints “Nikoo Hossein Khan Nazer”
